Altium Capital Management LP Catalyst Pharmaceuticals, Inc. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 255,000 shares of CPRX stock, worth $5.85 Million. This represents 1.77% of its overall portfolio holdings.
Number of Shares
255,000
Previous 385,000
33.77%
Holding current value
$5.85 Million
Previous $7.65 Million
30.47%
% of portfolio
1.77%
Previous 2.7%
Shares
4 transactions
Others Institutions Holding CPRX
# of Institutions
344Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$429 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$193 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$133 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$71.8 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$69.1 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.36B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...